Cargando…

Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease

High-density lipoprotein (HDL) is a lipid and protein complex that consists of apolipoproteins and lower level HDL-associated enzymes. HDL dysfunction is a factor in atherosclerosis and decreases patient survival. Mass spectrometry- (MS-) based proteomics provides a high throughput approach for anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Chiz-Tzung, Yang, Chao-Yuh, Tsai, Fuu-Jen, Lin, Shih-Yi, Chen, Chao-Jung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450224/ https://www.ncbi.nlm.nih.gov/pubmed/26090384 http://dx.doi.org/10.1155/2015/164846

Ejemplares similares

Urine proteome analysis by C(18) plate–matrix-assisted laser desorption/ionization time-of-flight mass spectrometry allows noninvasive differential diagnosis and prediction of diabetic nephropathy
por: Chen, Chao-Jung, et al.
Publicado: (2018)

High-Density Lipoprotein Nanoparticle Imaging in Atherosclerotic Vascular Disease
por: Leeper, Nicholas J., et al.
Publicado: (2017)

Urinary Proteomics for the Early Diagnosis of Diabetic Nephropathy in Taiwanese Patients
por: Liao, Wen-Ling, et al.
Publicado: (2018)

A Comparative Analysis of the Lipoprotein(a) and Low-Density Lipoprotein Proteomic Profiles Combining Mass Spectrometry and Mendelian Randomization
por: Bourgeois, Raphaëlle, et al.
Publicado: (2020)

SELDI-TOF mass spectrometry of High-Density Lipoprotein
por: Levels, Johannes HM, et al.
Publicado: (2007)

Electronegative Low-density Lipoprotein Increases Coronary Artery Disease Risk in Uremia Patients on Maintenance Hemodialysis
por: Chang, Chiz-Tzung, et al.
Publicado: (2016)

Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases
por: Ivanova, Ekaterina A., et al.
Publicado: (2017)

High-Density Lipoprotein (HDL) Triglyceride and Oxidized HDL: New Lipid Biomarkers of Lipoprotein-Related Atherosclerotic Cardiovascular Disease
por: Ito, Fumiaki, et al.
Publicado: (2020)

Electronegative low-density lipoprotein increases the risk of ischemic lower-extremity peripheral artery disease in uremia patients on maintenance hemodialysis
por: Chang, Chiz-Tzung, et al.
Publicado: (2017)

Rosiglitazone attenuates atherosclerosis and increases high-density lipoprotein function in atherosclerotic rabbits
por: LI, CHEN, et al.
Publicado: (2015)

Weight Gain After Smoking Cessation and Atherosclerotic Low-Density Lipoprotein Marker
por: Iida, Mami
Publicado: (2016)

High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease
por: Kosmas, Constantine E, et al.
Publicado: (2018)

Association between circulating oxidized low-density lipoprotein and atherosclerotic cardiovascular disease
por: Gao, Shen, et al.
Publicado: (2017)

Does low-density lipoprotein fully explain atherosclerotic risk in familial hypercholesterolemia?
por: Clarke, Shoa L.
Publicado: (2023)

Mass spectrometry-based proteomics in Chest Medicine, Gerontology, and Nephrology: subgroups omics for personalized medicine
por: Lin, Shih-Yi, et al.
Publicado: (2014)

Mass Spectrometry-Based Proteomics for Pre-Eclampsia and Preterm Birth
por: Law, Kai P., et al.
Publicado: (2015)

Proteomics and Mass Spectrometry for Cancer Biomarker Discovery
por: Lu, Ming, et al.
Publicado: (2007)

Proteome Profiling of Urinary Exosomes Identifies Alpha 1-Antitrypsin and H2B1K as Diagnostic and Prognostic Biomarkers for Urothelial Carcinoma
por: Lin, Shih-Yi, et al.
Publicado: (2016)

The comparison of CHCA solvent compositions for improving LC-MALDI performance and its application to study the impact of aflatoxin B1 on the liver proteome of diabetes mellitus type 1 mice
por: Tsai, Fuu-Jen, et al.
Publicado: (2017)

Mass spectrometry based proteomics profiling of human monocytes
por: Zeng, Yong, et al.
Publicado: (2016)

Salidroside Decreases Atherosclerotic Plaque Formation in Low-Density Lipoprotein Receptor-Deficient Mice
por: Zhang, Bu-Chun, et al.
Publicado: (2012)

Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very‐Low‐Density Lipoproteins
por: Lawler, Patrick R., et al.
Publicado: (2017)

Low-density lipoprotein cholesterol lowering therapy for the secondary prevention of atherosclerotic cardiovascular disease
por: Patel, Parth N., et al.
Publicado: (2020)

Associations of Monocytes and the Monocyte/High-Density Lipoprotein Ratio With Extracranial and Intracranial Atherosclerotic Stenosis
por: Liu, Zhu, et al.
Publicado: (2021)

High-density lipoprotein proteome dynamics in human endotoxemia
por: Levels, Johannes HM, et al.
Publicado: (2011)

Effects of Apolipoprotein A-I/High-Density Lipoprotein Cholesterol on Atherosclerotic Vascular Disease: Critical Impact of Atherosclerosis Disease Stage and Disease Milieu?
por: Haghikia, Arash, et al.
Publicado: (2018)

Development of biomarkers of genitourinary cancer using mass spectrometry-based clinical proteomics
por: Chen, Yi-Ting, et al.
Publicado: (2018)

Proteome discovery pipeline for mass spectrometry-based proteomics
por: Gough, Erik, et al.
Publicado: (2008)

A Statin-Loaded Reconstituted High-Density Lipoprotein Nanoparticle Inhibits Atherosclerotic Plaque Inflammation
por: Duivenvoorden, Raphaël, et al.
Publicado: (2014)

Mass Spectrometry for the Monitoring of Lipoprotein Oxidations by Myeloperoxidase in Cardiovascular Diseases
por: Coremans, Catherine, et al.
Publicado: (2021)

mspire: mass spectrometry proteomics in Ruby
por: Prince, John T., et al.
Publicado: (2008)

Computational Mass Spectrometry–Based Proteomics
por: Käll, Lukas, et al.
Publicado: (2011)

Comparing cellular proteomes by mass spectrometry
por: Fröhlich, Florian, et al.
Publicado: (2009)

Urine Proteomics in the Era of Mass Spectrometry
por: Beasley-Green, Ashley
Publicado: (2016)

Low triglyceride to high-density lipoprotein cholesterol ratio predicts hemorrhagic transformation in large atherosclerotic infarction of acute ischemic stroke
por: Deng, Qi-Wen, et al.
Publicado: (2019)

Dysfunctional High-Density Lipoprotein: An Innovative Target for Proteomics and Lipidomics
por: Salazar, Juan, et al.
Publicado: (2015)

Feasibility of Utilizing Stable-Isotope Dimethyl Labeling in Liquid Chromatography–Tandem Mass Spectrometry-Based Determination for Food Allergens—Case of Kiwifruit
por: Shih, Yi-Chen, et al.
Publicado: (2019)

Beneficial effects of omega-3 fatty acids in the proteome of high-density lipoprotein proteome
por: Burillo, Elena, et al.
Publicado: (2012)

Online Monitoring Oxidative Products and Metabolites of Nicotine by Free Radicals Generation with Fenton Reaction in Tandem Mass Spectrometry
por: Liang, Shih-Shin, et al.
Publicado: (2013)

Proteomic Analysis and Discovery Using Affinity Proteomics and Mass Spectrometry
por: Olsson, Niclas, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_bjdd1uk9nihjvqmvna0g2bc750